rs1554934109
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong
The NM_000543.5(SMPD1):c.362T>C(p.Leu121Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. L121L) has been classified as Likely benign.
Frequency
Consequence
NM_000543.5 missense
Scores
Clinical Significance
Conservation
Publications
- acid sphingomyelinase deficiencyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Niemann-Pick diseaseInheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health
- Niemann-Pick disease type AInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, G2P
- Niemann-Pick disease type BInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SMPD1 | NM_000543.5 | c.362T>C | p.Leu121Pro | missense_variant | Exon 2 of 6 | ENST00000342245.9 | NP_000534.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SMPD1 | ENST00000342245.9 | c.362T>C | p.Leu121Pro | missense_variant | Exon 2 of 6 | 1 | NM_000543.5 | ENSP00000340409.4 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Niemann-Pick disease, type A Pathogenic:1Uncertain:1
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
- -
not provided Pathogenic:1
Identified in the presence of a second SMPD1 variant in patients with clinical and biochemical features consistent with SMPD1-related acid sphingomyelinase deficiency referred for genetic testing at GeneDx and in the published literature (PMID: 36779112); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 26981555, 36779112) -
Sphingomyelin/cholesterol lipidosis Pathogenic:1
Variant summary: SMPD1 c.362T>C (p.Leu121Pro) results in a non-conservative amino acid change located in the saposin B type domain (IPR008139) of the encoded protein sequence. Four of four in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251300 control chromosomes (gnomAD). c.362T>C has been reported in the literature in individuals including homozygotes affected with Niemann-Pick Disease (examples: Reunert_2015; Velez-Pinos_2023). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 26981555, 36779112). ClinVar contains an entry for this variant (Variation ID: 556008). Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at